AGILENT TECHNOLOGIES, INC.
AHealthcareagilent.com
Latest available resultsJuly 31, 2026Quarter · 10-Q filed Sep 1, 2026
Next reportNovember 23, 2026after close · forecast 1.761 $/share
Revenue
$1.88B
▲ +8.1% vs prior year YoY
Net income
$362.00M
▲ +7.7% vs prior year YoY
EPS
1.28$
▲ +8.5% vs prior year YoY
Net margin
19.3%
▼ -0.1 pp vs prior year YoY
Revenue▲ +8.1%
Margins (% of revenue)GrossOperatingNet
Net income▲ +7.7%
EPS▲ +8.5%
Financial statements
View 10-Q filed September 1, 2026 on SEC ↗| Metric | Oct 2024* | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025* | Jan 2026 | Apr 2026 | Jul 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $1.70B | $1.68B | $1.67B | $1.74B | $1.86B | $1.80B | $1.83B | $1.88B | ▲ +8.1% |
| Gross profit | $916.00M | $899.00M | $866.00M | $888.00M | $990.00M | $946.00M | $990.00M | $1.04B | ▲ +17.3% |
| Operating income | $408.00M | $376.00M | $300.00M | $360.00M | $443.00M | $353.00M | $399.00M | $444.00M | ▲ +23.3% |
| Net income | $351.00M | $318.00M | $215.00M | $336.00M | $434.00M | $305.00M | $339.00M | $362.00M | ▲ +7.7% |
| R&D | $111.00M | $113.00M | $112.00M | $111.00M | $119.00M | $117.00M | $126.00M | $123.00M | ▲ +10.8% |
| EPS (diluted) | — | 1.11 $ | 0.75 $ | 1.18 $ | — | 1.07 $ | 1.20 $ | 1.28 $ | ▲ +8.5% |
| Margins (% of revenue) | |||||||||
| Gross | 53.9 % | 53.5 % | 51.9 % | 51.1 % | 53.2 % | 52.6 % | 54.0 % | 55.5 % | ▲ +4.4 pt |
| Operating | 24.0 % | 22.4 % | 18.0 % | 20.7 % | 23.8 % | 19.6 % | 21.7 % | 23.6 % | ▲ +2.9 pt |
| Net | 20.6 % | 18.9 % | 12.9 % | 19.3 % | 23.3 % | 17.0 % | 18.5 % | 19.3 % | ▼ -0.1 pt |
| Balance sheet | |||||||||
| Assets | $11.85B | $11.91B | $12.16B | $12.23B | $12.73B | $12.81B | $13.06B | $13.97B | ▲ +14.2% |
| Liabilities | $5.95B | $5.89B | $6.02B | $5.86B | $5.99B | $5.91B | $5.94B | $6.60B | ▲ +12.8% |
| Equity | −$305.00M | $6.03B | −$280.00M | −$283.00M | −$226.00M | −$184.00M | −$202.00M | −$233.00M | ▲ +17.7% |
| Cash | $1.33B | $1.47B | $1.49B | $1.53B | $1.79B | $1.76B | $1.81B | $1.76B | ▲ +14.5% |
| Capital | |||||||||
| Shares outstanding | 285.60M | 285.10M | 284.06M | 283.50M | 283.50M | 282.60M | 282.43M | 281.93M | ▼ -0.6% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.